journal article Jan 05, 2023

Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis

View at Publisher Save 10.1097/j.pain.0000000000002857
Abstract
Abstract
Evidence suggests an involvement of hypothalamic–pituitary–adrenal (HPA) axis dysregulation in the development and maintenance of fibromyalgia syndrome (FMS). However, studies on the stress response via the HPA-axis in individuals with FMS show conflicting results. To better understand the relationship between FMS and HPA-axis dysregulation, we (1) systematically summarized the current level of evidence on HPA biomarkers in individuals with FMS compared with individuals without and (2) evaluated whether FMS is associated with a specific pattern of HPA dysregulation. The main outcome measures were cortisol, adrenocorticotropic hormone (ACTH), corticotropin-releasing hormone (CRH), epinephrine, and norepinephrine. A systematic search of MEDLINE, EMBASE, and PsychMed yielded 47 studies eligible for meta-analysis, including 1465 individuals with FMS and 1192 FMS-free controls. No main effect of FMS was found on altered levels of blood cortisol, ACTH, CRH, and epinephrine. Compared with controls, salivary and urinary cortisol levels were decreased in individuals with FMS, whereas blood levels of norepinephrine were increased. However, heterogeneity of data was high with significant evidence for publication bias. Overall, the data are compatible with association of FMS with adrenocortical hypofunction in the presence of increased sympathetic tone. However, the data are partially contradictory, so it must be assumed that the data are highly dependent on the respective study designs, patient samples, and analytical methods and do not necessarily demonstrate an abnormal HPA-axis function in FMS.
Topics

No keywords indexed for this article. Browse by subject →

References
78
[1]
Adler "Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome" Am J Med (1999) 10.1016/s0002-9343(99)00074-1
[2]
Afari "Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis" Psychosomatic Med (2014) 10.1097/psy.0000000000000010
[3]
Al-Nimer "Dysfunction of anterior pituitary gland in women patients with recent fibromyalgia: a cross-sectional observational study" Electron J Gen Med (2018) 10.29333/ejgm/90278
[4]
Borchers "Fibromyalgia: a critical and comprehensive review" Clinic Rev Allerg Immunol (2015) 10.1007/s12016-015-8509-4
[5]
Bote "Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise" PLoS One (2013) 10.1371/journal.pone.0074524
[6]
Bote "Inflammatory/stress feedback dysregulation in women with fibromyalgia" Neuroimmunomodulation (2012) 10.1159/000341664
[7]
Cakit "Coexistence of fibromyalgia and metabolic syndrome in females: the effects on fatigue, clinical features, pain sensitivity, urinary cortisol and norepinephrine levels: a cross-sectional study" Arch Rheumatol (2021)
[8]
Chai "The value of HPA axis hormones as biomarkers for screening and early diagnosis of postpartum depression: updated information about methodology" Front Endocrinol (2022) 10.3389/fendo.2022.916611
[9]
Chervin "Objective measures of disordered sleep fibromyalgia" Joun Rheum (2009) 10.3899/jrheum.090051
[10]
Crofford "Hypothalamic–pituitary–adrenal axis perturbations in patients with fibromyalgia" Arthritis Rheum (1994) 10.1002/art.1780371105
[11]
Crofford "Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome" Brain Behav Immun (2004) 10.1016/j.bbi.2003.12.011
[12]
de Abreu Freitas "Influence of cortisol and DHEA-S on pain and other symptoms in post menopausal women with fibromyalgia" J Back Musculoskelet Rehabil (2012) 10.3233/bmr-2012-0331
[13]
El-Farhan "Measuring cortisol in serum, urine and saliva—are our assays good enough?" Ann Clin Biochem (2017) 10.1177/0004563216687335
[14]
Fries "A new view on hypocortisolism" Psychoneuroendocrinology (2005) 10.1016/j.psyneuen.2005.04.006
[15]
Galvez-Sánchez "Psychological impact of fibromyalgia: current perspectives" Psychol Res Behav Manag (2019) 10.2147/prbm.s178240
[16]
Geiss "Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia" Psychoneuroendocrinology (2012) 10.1016/j.psyneuen.2011.07.021
[17]
González-Vives "Hypothalamic-pituitary axis response to a 0.25-MG dexamethasone test in women with fibromyalgia" Stress (2020) 10.1080/10253890.2019.1678024
[18]
Grouzmann "Determination of catecholamines in plasma and urine" Best Pract Res Clin Endocrinol Metab (2013) 10.1016/j.beem.2013.06.004
[19]
Gur "Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones" Arthritis Res Ther (2004) 10.1186/ar1163
[20]
Gur "Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism" Ann Rheum Dis (2004) 10.1136/ard.2003.014969
[21]
Gürsel "Hormonal responses to exercise stress test in patients with fibromyalgia syndrome" Clin Rheumatol (2001) 10.1007/s100670170003
[22]
Heim "Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction" Arch Gen Psychiatry (2009) 10.1001/archgenpsychiatry.2008.508
[23]
Heim "Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood" JAMA (2000) 10.1001/jama.284.5.592
[24]
Hellhammer "Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state-and trait components" Psychoneuroendocrinology (2007) 10.1016/j.psyneuen.2006.10.005
[25]
Quantifying heterogeneity in a meta‐analysis

Julian P. T. Higgins, Simon G. Thompson

Statistics in Medicine 2002 10.1002/sim.1186
[26]
Illescas-Montes "Application of salivary biomarkers in the diagnosis of fibromyalgia" Diagnostics (2021) 10.3390/diagnostics11010063
[27]
Izquierdo–Álvarez "Is there an association between fibromyalgia and below-normal levels of urinary cortisol? BMC Research Notes" (2008)
[28]
Kadetoff "Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia" J Rehabil Med (2010) 10.2340/16501977-0597
[29]
Kaufmann "Anandamide and neutrophil function in patients with fibromyalgia" Psychoneuroendocrinology (2008) 10.1016/j.psyneuen.2008.02.009
[30]
Keeshin "Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms" J Child Adolesc Psychopharmacol (2015) 10.1089/cap.2014.0034
[31]
Kleshchova "Resting amygdala connectivity and basal sympathetic tone as markers of chronic hypervigilance" Psychoneuroendocrinology (2019) 10.1016/j.psyneuen.2018.11.036
[32]
Klingmann "Sex‐specific prenatal programming: a risk for fibromyalgia?" Ann N Y Acad Sci (2008) 10.1196/annals.1410.020
[33]
Koca "The association of carotid intima-media thickness with body mass index and cortisol level in fibromyalgia syndrome" Eur Res J (2019) 10.18621/eurj.376343
[34]
Kozlov "Cortisol as stress marker" Fiziol Chel (2014)
[35]
Kumbhare "Potential role of blood biomarkers in patients with fibromyalgia: a systematic review with meta-analysis" PAIN (2022) 10.1097/j.pain.0000000000002510
[36]
Latendresse "Bioassay research methodology: measuring CRH in pregnancy" Biol Res Nurs (2008) 10.1177/1099800408320970
[37]
Lee "Technical and clinical aspects of cortisol as a biochemical marker of chronic stress" BMB Rep (2015) 10.5483/bmbrep.2015.48.4.275
[38]
Lentjes "Glucocorticoid receptors, fibromyalgia and low back pain" Psychoneuroendocrinology (1997) 10.1016/s0306-4530(97)00061-9
[39]
Adrenergic Dysregulation and Pain With and Without Acute Beta-Blockade in Women With Fibromyalgia and Temporomandibular Disorder

Kathleen C. Light, Edith E. Bragdon, Karen M. Grewen et al.

The Journal of Pain 2009 10.1016/j.jpain.2008.12.006
[40]
Salivary cortisol is associated with cognitive changes in patients with fibromyalgia

Yi-Ju Lin, Yu-Chieh Ko, Lok-Hi Chow et al.

Scientific Reports 2021 10.1038/s41598-020-79349-0
[41]
Macedo "Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper" Psychoneuroendocrinology (2008) 10.1016/j.psyneuen.2008.03.012
[42]
McEwen "What is the confusion with cortisol?" Chronic Stress (2019) 10.1177/2470547019833647
[43]
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.

Gregory E. Miller, Edith Chen, Eric S. Zhou

Psychological Bulletin 2007 10.1037/0033-2909.133.1.25
[44]
Moher "Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement" Phys Ther (2009) 10.1093/ptj/89.9.873
[45]
Mouraux "The search for pain biomarkers in the human brain" Brain (2018) 10.1093/brain/awy281
[46]
Nestler "Neurobiology of depression" Neuron (2002) 10.1016/s0896-6273(02)00653-0
[47]
The IASP classification of chronic pain for ICD-11: chronic primary pain

Michael Nicholas, Johan W.S. Vlaeyen, Winfried Rief et al.

Pain 2019 10.1097/j.pain.0000000000001390
[48]
Nilsen "Autonomic activation and pain in response to low-grade mental stress in fibromyalgia and shoulder/neck pain patients" Eur J Pain (2007) 10.1016/j.ejpain.2006.11.004
[49]
Noushad "Physiological biomarkers of chronic stress: a systematic review" Int J Health Sci (2021)
[50]
Ortega "Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances" Exerc Immunol Rev (2009)

Showing 50 of 78 references

Metrics
45
Citations
78
References
Details
Published
Jan 05, 2023
Vol/Issue
164(7)
Pages
1416-1427
Cite This Article
Eva Beiner, VICTORIA LUCAS, Julian Reichert, et al. (2023). Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis. Pain, 164(7), 1416-1427. https://doi.org/10.1097/j.pain.0000000000002857